Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Clinical trial NCT02178592 · COMPLETED
Trial details
- NCT number
- NCT02178592
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-23
- Primary completion
- 2017-11-02
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.